World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
17486
World Ranking
14173
National Ranking
141

Amnon Peled publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Amnon Peled sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 201 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Amnon Peled D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Amnon Peled sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Amnon Peled is affiliated with the Hebrew University of Jerusalem in Israel and specializes in the field of Medicine, with a focus on Oncology, Immunology, Hematology, Hepatology, and Molecular Biology. Their body of work encompasses research on immune cell function and interaction, cancer immunotherapy and biomarkers, liver physiology and pathology, pancreatic and hepatic oncology, phagocytosis and immune regulation, multiple myeloma research and treatments, and chemokine receptors and signaling.

Peled has authored several notable scientific papers, including:

  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial, 2020, Nature Medicine
  • Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial, 2021, Clinical Cancer Research
  • Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling, 2022, Journal of Hepatology
  • Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response, 2020, Journal of Hematology & Oncology
  • CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression, 2022, Journal of Hematology & Oncology

Frequent co-authors in Peled's collaborations include:

  • Michal Abraham
  • Stefan Rose-John
  • Eithan Galun
  • Inbal Mishalian
  • Nofar Rosenberg

Peled's research has been published repeatedly in several key scientific venues, such as:

  • Journal of Hepatology
  • Cancer Research
  • Blood
  • Regular and Young Investigator Award Abstracts
  • Journal of Hematology & Oncology

Their research topics frequently address areas including:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Liver Physiology and Pathology
  • Pancreatic and Hepatic Oncology Research
  • Phagocytosis and Immune Regulation
  • Multiple Myeloma Research and Treatments
  • Chemokine Receptors and Signaling

Best Publications

  • Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

    Amnon Peled;Isabelle Petit;Orit Kollet;Michal Magid

  • G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

    Isabelle Petit;Martine Szyper-Kravitz;Arnon Nagler;Meir Lahav

  • The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

    Amnon Peled;Orit Kollet;Tanya Ponomaryov;Isabelle Petit

  • Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function

    Tanya Ponomaryov;Amnon Peled;Isabelle Petit;Russell S. Taichman

  • The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow

    Amnon Peled;Valentin Grabovsky;Liliana Habler;Judith Sandbank

  • CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.

    Abraham Avigdor;Polina Goichberg;Shoham Shivtiel;Ayelet Dar

  • CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

    J A Burger;A Peled

  • Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

    Merav Darash-Yahana;Eli Pikarsky;Rinat Abramovitch;Evelyne Zeira

  • Subsecond Induction of α4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions

    Valentin Grabovsky;Sara Feigelson;Chun Chen;Diederik A. Bleijs

  • Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.

    Orit Kollet;Asaf Spiegel;Amnon Peled;Isabelle Petit

  • CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells.

    Jacob Hanna;Ori Wald;Debra Goldman-Wohl;Diana Prus

  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Bruno Bockorny;Bruno Bockorny;Valerya Semenisty;Teresa Macarulla;Erkut Borazanci

  • Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents

    R. Eldor;A. Yeffet;K. Baum;V. Doviner

  • Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

    Mitchell E. Horwitz;Nelson J. Chao;David A. Rizzieri;Gwynn D. Long

  • β2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function

    Orit Kollet;Orit Kollet;Amnon Peled;Amnon Peled;Tamara Byk;Tamara Byk;Herzl Ben-Hur;Herzl Ben-Hur

  • Critical Involvement of the Chemotactic Axis CXCR4/Stromal Cell-Derived Factor-1α in the Inflammatory Component of Allergic Airway Disease

    Jose-Angel Gonzalo;Clare M. Lloyd;Amnon Peled;Tracy Delaney

  • Atypical PKC-ζ regulates SDF-1–mediated migration and development of human CD34+ progenitor cells

    Isabelle Petit;Polina Goichberg;Asaf Spiegel;Amnon Peled

  • Human CD34+CXCR4− sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation

    Orit Kollet;Isabelle Petit;Joy Kahn;Sarit Samira

  • Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment

    Tony Peled;Hadas Shoham;Dorit Aschengrau;Dima Yackoubov

  • Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling

    Asaf Spiegel;Orit Kollet;Amnon Peled;Loya Abel

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Eithan Galun
Eithan Galun Hebrew University of Jerusalem
Tsvee Lapidot
Tsvee Lapidot Weizmann Institute of Science
Ronen Alon
Ronen Alon Weizmann Institute of Science
Orit Kollet
Orit Kollet Weizmann Institute of Science
Dov Zipori
Dov Zipori Weizmann Institute of Science
Eli Pikarsky
Eli Pikarsky Hebrew University of Jerusalem
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Jan A. Burger
Jan A. Burger The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Biology or Biochemistry opens doors to various healthcare and science careers, and online study options are rapidly expanding. Pursuing an online healthcare mba is a popular pathway for those aiming to enter management roles within hospitals, research institutions, or biotech companies. These programs allow for enhanced flexibility and affordability while preparing graduates for leadership positions.

For those interested in the technical side of healthcare, medical billing and coding offers a fast-growing and accessible career path. It's important to compare the certified coding specialist certifications, as different certifications can lead to different job opportunities and salary potential. Aspiring professionals often wonder how long does it take to become a medical coder; training can typically be completed in under a year, making it an efficient route into the healthcare sector.

If you are thinking about job security, it’s worth exploring is medical billing and coding in demand. These roles remain essential to healthcare operations, offering strong growth prospects and opportunities for career advancement—making them attractive options for Biology and Biochemistry graduates.

Best Scientists Citing Amnon Peled

Trending Scientists

Recently Published Articles